Clinical trial
Development Platform Construction and Application Promotion of Drug-Eluting Stents for Intracranial Aneurysm Interventional Therapy
NCT07190781 is registered in ClinicalTrials.gov with Xinjian Yang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development Platform Construction and Application Promotion of Drug-Eluting Stents for Intracranial Aneurysm Interventional Therapy
- Lead sponsor
- Xinjian Yang
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- October 24, 2022
- Completion date
- December 31, 2026
- Enrollment
- 280 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral aneurysm unruptured